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Background: To assess prevalence rates of subjective and objective reports of two cardiovascular disorders
(hypertension and hypercholesterolemia) for the same subset of respondents in a large-scale study. To determine
whether and the extent to which the socioeconomic health gradient differed in the subjective and objective
reports of the two cardiovascular disorders.
Methods: Data from the first wave (2009/2011) of The Irish Longitudinal Study on Ageing were used (n = 4,179).
This is a nationally representative study of community-dwelling adults aged 50+ residing in Ireland. Subjective
measures were derived from self-reports of doctor-diagnosed hypertension and high cholesterol. Objective measure
of hypertension was defined as: systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg
and/or on antihypertensive medication. Objective measure of hypercholesterolemia was defined as: total
cholesterol ≥5.2 mmol/L and/or on cholesterol-lowering medication. Objective measures of low-density-lipoprotein
cholesterol and high-density-lipoprotein cholesterol were also used. Two measures of socioeconomic gradient were
employed: education and wealth. Binary and multinomial logistic and linear regression analyses were used. Analyses
were adjusted for an extensive battery of covariates, including demographics and measures of physical/behavioural
health and health care utilization.
Results: Prevalence of cardiovascular disorders: prevalence of hypertension and hypercholesterolemia was
significantly higher when the cardiovascular disorders were measured objectively as compared to self-reports (64%
and 72.1% versus 37% and 41.1%, respectively). Socioeconomic gradient in hypertension: the odds of being
objectively hypertensive were significantly lower for individuals with tertiary/higher education (OR, 0.74; 95% CI,
0.60-0.92) and in the highest tertile of the wealth distribution (OR, 0.77; 95% CI, 0.62-0.95). In contrast, the
associations between socioeconomic status and self-reported hypertension were not statistically significant.
Socioeconomic gradient in hypercholesterolemia: wealthier individuals had higher odds of self-reporting elevated
cholesterol (OR, 1.28; 95% CI, 1.03-1.58). Associations between socioeconomic status and objectively measured
hypercholesterolemia and low-density-lipoprotein cholesterol were not significant. Higher education and, to a lesser
extent, greater wealth were associated with higher levels of high-density-lipoprotein cholesterol.
Conclusions: Clear discrepancies in prevalence rates and gradients by socioeconomic status were found between
subjective and objective reports of both disorders. This emphasizes the importance of objective measures when
collecting population data.* Correspondence: moscai@tcd.ie
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Previous research has shown that gradients in poor health
by socioeconomic status (SES) exist [1-11]. Most studies
have used self-reported measures of health status and, to a
lesser extent, self-reported chronic health conditions.
These measures are attractive because they are relatively
inexpensive to collect in large-scale surveys and a powerful
independent predictor of future morbidity and mortality
[12-15] and health care utilization [16,17]. Nevertheless,
there are growing concerns that findings based on self-
reported measures of health may be biased if such mea-
sures suffer from reporting error and, in particular, if the
reporting error varies with SES. Evidence that reporting er-
rors undermine the robustness of the findings on socioeco-
nomic gradients (SEGs) in health has been found in the US
and in Europe [18-21]. An attractive alternative is to use
objective measures of health status. These measures are,
however, expensive to collect and hence rarely collated in
large population studies.
The contribution of this article to the literature is two-
fold. First, this article assesses prevalence rates of subject-
ive and objective reports of two cardiovascular disorders
(hypertension and hypercholesterolemia) in a nationally
representative study of older individuals residing in Ireland
(The Irish Longitudinal Study on Ageing (TILDA)).
TILDA is rare in containing both subjective and objective
measures of the same condition for the same respondents
and in the depth and quality of the objective measures col-
lected. Second, this article investigates whether and the
extent to which the socioeconomic health gradient differs
in the subjective and objective reports of the two cardio-
vascular disorders.
Methods
Source data
Data from the first wave (2009/2011) of The Irish Longitu-
dinal Study on Ageing (TILDA) were used. This is a
nationally representative study of community-dwelling
adults aged 50+ (and their spouses or partners of any age)
residing in Ireland. The study is closely harmonised with
leading international research, including The English Lon-
gitudinal Study of Ageing (ELSA), the Survey of Health,
Ageing and Retirement in Europe (SHARE) which is pan-
European, and the Health and Retirement Survey (HRS)
conducted in the United States.
A total of 8,504 participants were recruited to the study
(8,175 aged 50+ and 329 younger partners of eligible indi-
viduals). Ethical approval was obtained from the Trinity
College Dublin Research Ethics Committee, and all partic-
ipants provided written informed consent. Participants
first completed a computer-assisted personal interview
(CAPI) in their own homes. If individuals had known or
suspected dementia, they were ineligible for participation
in the study. The overall response rate was 62%.Participants attended a health centre for a comprehen-
sive health assessment. Participants who were unable/
unwilling to attend were offered a modified and partial
assessment in their own home. All assessments were
carried out by qualified and trained research nurses.
Among other clinical parameters, cardiovascular mea-
sures were assessed and collated. Of the 8,175 partici-
pants aged 50+, 5,897 underwent an assessment (85.4%
in the health assessment and 15.6% in their own home).
Details of the health assessment have been reported else-
where [22].
Outcome variables: subjective and objective measures
of cardiovascular disorders
TILDA collected data on individual self-reports of spe-
cific conditions with the general question: “Has the doc-
tor ever told you have any of the following conditions
on this card?” The diagnoses analyzed in this paper are:
hypertension and high cholesterol.
TILDA also collected data on objective evidence of
these cardiovascular disorders. Focusing first on hyper-
tension, objective measurements of blood pressure were
taken by TILDA research nurses in the health or home
assessment. Blood pressure was measured using the
OMRON™ digital automatic blood pressure monitor
with arm cuff (Model M10-IT). Participants had been
seated for at least 30 minutes when the measurement
was obtained. Three separate readings were taken one
minute apart; the first two with the respondent seated
and the third immediately after the respondent stood up.
The mean value for seated blood pressure from the first
and second readings was used in this analysis.
Objective hypertension was defined as systolic blood
pressure (SBP) ≥ 140 mm Hg and/or diastolic blood
pressure (DBP) ≥ 90 mm Hg and/or on antihypertensive
medication [11,23,24]. Data on medication was collected
in the CAPI. Respondents were asked to show the pack-
aging (bottle, tube, blister pack) of the medications they
were taking on a regular basis to the interviewer, who
then recorded the names of the medications into a
computer-based medication inventory. All medications
were then classified according to the WHO Anatomical
Therapeutic Chemical (ATC) classification system. This
ensured that drugs were classified in a standardized way,
according to primary indication. We considered antihy-
pertensive medication to include respondents taking
antiadrenergic agents, diuretics, beta blocking agents,
calcium channel blockers and ACE inhibitors.
Non-fasting blood samples were collected from
TILDA respondents in the health or home assessment.
Measurements of total cholesterol, HDL-C (high-dens-
ity-lipoprotein cholesterol) and LDL-C (low-density-
lipoprotein cholesterol) were taken. Respondents were
defined as having objective hypercholesterolemia if: total
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medication. We considered cholesterol-lowering medica-
tion to encompasse HMG CoA reductase inhibitors,
fibrates, bile acid sequestrants, nicotinic acid derivatives
and other lipid modifying agents such as ezetimibe, as
well as lipid lowering drugs in combination with other
agents. Measurements of HDL-C and LDL-C were also
used in our analyses.
Measures of SES
Two key SES measures were used in this study: educa-
tional attainment and wealth, each divided into three
groups. Education was separated into: ‘no/primary’, ‘sec-
ondary’ (junior certificate, leaving certificate or equiva-
lent), and ‘tertiary/higher’ (diploma, first degree or higher).
Data on wealth was collected through a battery of ques-
tions on self-valuation of: current residence, properties
other than current residence, cars, savings, other financial
assets and other assets including business and land.
Unfolding brackets were used when respondents refused
or said that they “did not know” the value of their house,
other financial assets or other assets. The unfolding
brackets technique is often used in empirical studies to re-
duce item non-response on financial measures [25].
Unfortunately, unfolding brackets were not employed
after the question on savings. Hence, savings were im-
puted for those respondents who, although did not pro-
vide an estimate of savings, provided information on all
the other assets (N = 742). Multiple imputation was
performed using the multiple imputation suite (mi) of
commands available is STATA 12 [26]. The mi set of com-
mands was used to generate a regression model to impute
missing data based on a range of conditional covariates.
The predictive mean matching method was used. This is a
partially parametric model that matches the missing value
to the observed value with the closest predicted mean
[26-28]. A total of five nearest neighbours were included
in the set of possible donors [28]. This process was re-
peated 20 times, creating 20 separated imputed datasets.
These 20 datasets were finally combined into one dataset.
The wealth gradient was then constructed by dividing re-
spondents in tertiles.
Other covariates
A wide battery of controls was added to the model. These
included: i) demographic and socio-economic characteris-
tics: sex, single year of age, marital status (married/
cohabiting or not), current area of residence (Dublin, an-
other town/city, rural area), whether respondent grew up
in a poor family or not (self-reported); ii) risk factors asso-
ciated with cardiovascular disease: smoking (current
smoker, past smoker, never smoked), drinking (standard
alcoholic drinks per week and CAGE (cut-annoyed-guilty-
eye opener) questionnaire score) [29,30], exercise(kilocalories burnt per week doing physical activity) and
waist circumference in centimetres; iii) self-report of
doctor-diagnosed diabetes; iv) multiple other doctor-
diagnosed cardiovascular diseases specifically angina, heart
attack, congestive heart failure, stroke, ministroke or tran-
sient ischemic attack, abnormal heart rhythm, heart mur-
mur and any other heart trouble; v) health care utilization:
number of times visited a physician or a hospital in the
year prior to the interview (self-reported); and vi) health
insurance coverage: private (yes/no), full public i.e. free
health care (yes/no), partial public (yes/no). The regres-
sions on hypercholesterolemia also included a dichotom-
ous variable for whether the respondent reported to have
had at least one blood test for cholesterol.
Statistical methods
Binary and multinomial logistic and linear regression
analyses were used. Analyses were first adjusted only for
age and sex. Subsequently, the full battery of covariates
was entered simultaneously. All models used appropriate
sample weights and included 4,179 observations. Ana-
lyses were performed using STATA 12 [31]. A prior level
of significance was set at p ≤ 0.05 for all analyses.
First, the associations between SES and self-reported and
objectively measured hypertension and hypercholesterol-
emia were investigated. Binary logistic regressions were
used and odd ratios (ORs) and 95% confidence intervals
(CIs) were reported. Then, the associations between SES
and objectively measured hypertension, LDL-C and HDL-C
were investigated more closely. Multinomial logistic regres-
sions were used for objective hypertension and, for ease of
interpretation, parameter estimates were converted to esti-
mates of average marginal effects (AMEs). Linear regres-
sions were used for objective measures of LDL-C and
HDL-C and coefficients (and 95% CIs) were reported.
Results
Baseline characteristics of the source population are shown
in Table 1. The prevalence of hypertension and hypercholes-
terolemia was significantly higher when the cardiovascular
disorders were measured objectively, for all the education
and wealth categories. Focusing on the SES, the prevalence
rates of self-reported and objectively measured hypertension
were higher among those at the bottom of either the educa-
tion or wealth ladder compared with those at the top of each
classification. In contrast, the prevalence of self-reported
high cholesterol and objectively measured hypercholesterol-
emia was higher among those with tertiary/higher education
or in the third tertile of the wealth distribution.
SES in self-reported and objectively measured
hypertension and hypercholesterolemia
Table 2 shows the associations between SES and self-
reported and objectively measured hypertension (Panel
Table 1 Baseline characteristics by educational attainment and wealth tertile
Education Wealth Total
No/primary Secondary Tertiary/ higher 1st tertile 2nd tertile 3rd tertile
Unweighted sample size 1,089 1,741 1,349 940 1,172 1,325 4,179
Outcome variables
Self-reported CVDs:
Hypertension 44.8 32.8 30.8 38.4 38.2 31.5 37.0
High cholesterol 41.5 39.8 43.7 38.7 39.7 45.5 41.1
Objectively measured CVDs:
Hypertensiona 74.3 59.9 52.4 69.2 63.3 57.7 64.0
Hypercholesterolemiab 71.9 71.2 74.6 70.9 71.9 72.4 72.1
LDL-cholesterol, mean 2.8 2.9 3.0 2.9 2.9 2.9 2.9
HDL-cholesterol, mean 1.5 1.5 1.6 1.5 1.5 1.6 1.5
Covariates
Male 48.8 47.9 52.6 46.8 48.3 54.4 49.1
Age, mean 68.4 60.9 60.4 64.9 62.9 61.6 63.7
Married/cohabiting 60.3 74.9 74.9 52.6 70.6 83.2 69.4
Place of residence:
Dublin 25.1 23.7 36.2 21.5 20.4 40.0 26.5
Another town/city 25.4 28.1 25.0 30.5 28.2 19.0 26.5
Rural area 49.5 48.2 38.9 48.1 51.4 41.0 46.9
Grew up in poor family 36.0 19.2 13.9 32.4 24.9 18.1 24.6
Smoking:
Current smoker 19.5 17.0 11.3 27.4 14.9 11.0 16.9
Past smoker 40.9 36.9 40.1 36.9 42.4 37.2 39.1
Never smoked 39.5 46.1 48.6 35.7 42.7 51.8 44.0
Drinking:c
Alcoholic drinks per week, mean 4.6 6.2 6.8 5.9 5.1 6.9 5.8
CAGE score≤1 76.7 78.0 77.1 74.7 78.0 78.8 77.4
CAGE score≥2 8.9 12.7 15.0 11.9 11.0 13.4 11.7
Kilocalories burnt per week, mean 3596.9 4183.5 4284.5 3339.8 3778.6 4594.4 3979.1
Waist circumference, mean 97.8 95.3 94.5 97.0 96.6 95.0 96.1
Self-reported diabetes 9.5 6.3 5.2 8.5 7.0 6.2 7.3
Self-reported other CVDs, mean 0.3 0.2 0.2 0.3 0.2 0.2 0.2
Visits to physician/H last year, mean 7.2 5.3 4.7 7.3 6.2 4.6 5.9
Health insurance coverage:
Private 33.8 63.9 81.8 26.9 52.6 84.3 55.8
Full public 72.5 39.2 22.3 71.2 50.9 22.6 48.7
Partial public 1.9 2.0 1.3 2.7 2.6 0.6 1.8
Tested for cholesterol 90.5 88.1 90.1 86.2 89.7 91.0 89.3
Values are expressed as percentages unless otherwise indicated. Sample weights are applied. Baseline characteristics for ‘Education’ and ‘Total’ are reported for
N = 4,179. Baseline characteristics for ‘Wealth’ are reported for N = 3,437.
Abbreviations: CVD Cardiovascular disorder, LDL Low-density lipoprotein, HDL High-density lipoprotein, H Hospital.
aDefined as: systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg and/or on antihypertensive medication (ATC codes: C02 (A-D,K,L,N),
C03, C04, C07-C09).
bDefined as: total cholesterol ≥5.2 mmol/L and/or on cholesterol lowering medication (ATC code: C10A (A-D, X) and C10B).
cQuestions on alcohol intake and the CAGE questionnaire were asked in the self-completion questionnaire. Hence, information on alcohol intake and CAGE score
is missing for respondents who underwent the health or home assessment but did not return the self-completion questionnaire.
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Table 2 Associations [95% confidence intervals] between SES (education and wealth) and self-reported and objectively
measured hypertension and hypercholesterolemia
Education Wealth
No/primary Secondary Tertiary/higher 1st tertile 2nd tertile 3rd tertile
Panel 1: Hypertension
Self-reporteda
Adjusted for age, sex 1 [Ref] 0.83 [0.70–0.99]* 0.79 [0.65–0.95]* 1 [Ref] 1.04 [0.86–1.25] 0.84 [0.70–1.00]*
Adjusted for age, sex & covariates 1 [Ref] 0.94 [0.77–1.14] 0.92 [0.74–1.15] 1 [Ref] 1.17 [0.95–1.45] 0.99 [0.79–1.25]
Objectively measureda
Adjusted for age, sex 1 [Ref] 0.83 [0.69–1.00]* 0.60 [0.50–0.73]** 1 [Ref] 0.78 [0.65–0.93]** 0.65 [0.55–0.77]**
Adjusted for age, sex & covariates 1 [Ref] 0.96 [0.79–1.18] 0.74 [0.60–0.92]** 1 [Ref] 0.86 [0.71–1.05] 0.77 [0.62–0.95]*
Panel 2: Hypercholesterolemia
Self-reporteda
Adjusted for age, sex 1 [Ref] 0.99 [0.84–1.17] 1.18 [0.99–1.41] 1 [Ref] 0.98 [0.82–1.17] 1.25 [1.06–1.48]**
Adjusted for age, sex & covariates 1 [Ref] 0.98 [0.81–1.18] 1.13 [0.92–1.38] 1 [Ref] 0.96 [0.79–1.17] 1.28 [1.03–1.58]*
Objectively measureda
Adjusted for age, sex 1 [Ref] 0.97[0.81–1.16] 1.19 [0.98–1.45] 1 [Ref] 1.10 [0.92–1.32] 1.10 [0.92–1.31]
Adjusted for age, sex & covariates 1 [Ref] 0.96 [0.80–1.16] 1.13 [0.90–1.42] 1 [Ref] 1.10 [0.91–1.34] 1.05 [0.85–1.30]
Abbreviation: Ref Reference category.
aBinary logistic regression was performed. Association is odds ratio. The full list of covariates is presented in Table 1.
*Indicates statistical significance at the 5% level.
**Indicates statistical significance at the 1% level.
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that, in the analyses adjusted for age and sex, the odds
of reporting doctor-diagnosed hypertension were lower
for individuals with tertiary/higher education (p < 0.05)
and in the highest tertile of the wealth distribution (p <
0.05). However, adjustment for the full battery of covari-
ates reduced these associations, such that they were no
longer significant. In contrast, the odds of being object-
ively hypertensive remained significantly lower for indi-
viduals with tertiary/higher education (p < 0.01) and in
the highest tertile of the wealth distribution (p < 0.05)
even after full adjustment.
Panel 2, Table 2 shows that, in the analyses adjusted for
age and sex, individuals in the third tertile of the wealth
distribution had higher odds of reporting doctor-
diagnosed hypercholesterolemia (p < 0.01). The association
remained significant even after full adjustment (p < 0.05).
The association between SES and objectively measured
hypercholesterolemia was not significant at 5% level.
A closer look at SES in objectively measured
hypertension, LDL-C and HDL-C
Panel 1, Table 3 shows the associations between SES and
objectively measured hypertension in the multinomial
logistic regression framework. Four mutually exclusive
and exhaustive non-ordered outcome categories were
identified: 1) not hypertensive (SBP < 140 mm Hg and
DBP < 90 mm Hg and not on antihypertensive medica-
tion); 2) hypertensive and treated optimally (SBP <140 mm Hg and DBP < 90 mm Hg and on antihyperten-
sive medication); 3) hypertensive and treated sub-
optimally (SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg
and on antihypertensive medication); 4) hypertensive
and untreated (SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm
Hg and not on antihypertensive medication). The full
battery of covariates was employed. Panel 1, Table 3
shows that the probability of being ‘not hypertensive’ (1)
was 5.5 percentage points higher for individuals with ter-
tiary/higher education (p < 0.01) and 4.7 percentage
points higher in the highest tertile of the wealth distribu-
tion (p < 0.05). At the same time, the probability of being
hypertensive and untreated (4) was lower for individuals
in the second (p < 0.01) and third (p < 0.05) tertiles of
the wealth distribution.
Panel 2, Table 3 displays the associations of SES with ob-
jectively measured LDL-C and HDL-C in the linear re-
gression framework. The associations of education (and
wealth) and LDL-C were not significant at 5% level. How-
ever, higher education and, to a lesser extent, greater
wealth were associated with higher levels of HDL-C. In
the analyses adjusting for age and sex, the coefficient of
‘tertiary/higher education’ was 0.11 (p < 0.01) and de-
creased to 0.05 (p < 0.01) after full adjustment.
Discussion
Cardiovascular disease is the leading cause of death both
in Ireland and Europe [32]. Our analysis revealed that
64% of the older Irish population were objectively
Table 3 Associations [95% confidence intervals] between SES (education and wealth) and objectively measured
hypertension, LDL-cholesterol and HDL-cholesterol
Education Wealth
No/primary Secondary Tertiary/higher 1st tertile 2nd tertile 3rd tertile
Panel 1: Objectively Measured Hypertensiona
1) Not hypertensive 1 [Ref] 0.7 [−3.0 to 4.5] 5.5 [1.4 to 9.7]** 1 [Ref] 2.7 [−0.9 to 6.4] 4.7 [0.7 to 8.8]*
Hypertensive, divided in 3 sub-groups:
2) Optimally treated 1 [Ref] −1.9 [−5.0 to 1.2] −2.3 [−5.8 to 1.1] 1 [Ref] 1.4 [−1.8 to 4.5] −1.6 [−5.2 to 2.0]
3) Sub-optimally treated 1 [Ref] −0.6 [−3.7 to 2.4] −1.1 [−4.6 to 2.5] 1 [Ref] 1.5 [−1.6 to 4.7] 1.1 [−2.6 to 4.8]
4) Untreated 1 [Ref] 1.8 [−1.6 to 5.3] −2.2 [−6.1 to 1.8] 1 [Ref] −5.6 [−9.3 to −1.9]** −4.3 [−8.3 to −0.3]*
Panel 2: Objectively Measured Cholesterolb
LDL-C
Adjusted for age, sex 1 [Ref] −0.02 [−0.09-0.05] 0.04 [−0.04-0.12] 1 [Ref] 0.01 [−0.07-0.10] 0.02 [−0.06-0.10]
Adjusted for age, sex & covariates 1 [Ref] −0.03[−0.10-0.05] 0.00[−0.08-0.09] 1 [Ref] 0.02 [−0.07-0.10] 0.00 [−0.09-0.09]
HDL-C
Adjusted for age, sex 1 [Ref] 0.05 [0.02-0.08]** 0.11 [0.07-0.15]** 1 [Ref] 0.02 [−0.01-0.06] 0.09 [0.06-0.12]**
Adjusted for age, sex & covariates 1 [Ref] 0.02 [−0.01-0.05] 0.05 [0.01-0.09]** 1 [Ref] 0.00 [−0.03-0.03] 0.03 [0.00-0.07]
Abbreviation: Ref, reference category.
a1): SBP < 140 mm Hg and DBP < 90 mm Hg and not on antihypertensive medication (36%); 2): SBP < 140 mm Hg and DBP < 90 mm Hg and on antihypertensive
medication (25.5%); 3): SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg and on antihypertensive medication (19.1%); 4): SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg and
not on antihypertensive medication (19.3%). Multinomial logistic regression was performed, adjusting for age, sex, and covariates. Association is average
marginal effect.
bLinear regression was performed. Association is coefficient.
*Indicates statistical significance at the 5% level.
**Indicates statistical significance at the 1% level.
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compared to international prevalence rates when one
considers our sample is relatively young (59.7% are in
the 50–64 age-group). A review published in 2005 inves-
tigated the global burden of objective hypertension
through analysis of worldwide data and found that in
established market economies the prevalence rate of
hypertension for the 50–59 and the 60–69 age groups
was 44.8% and 60.3% respectively for men and 42% and
58.7% for women [24]. Crucially this study defined ob-
jective hypertension as we did (SBP ≥ 140 mm Hg and/
or DBP ≥ 90 mm Hg and/or on antihypertensive medica-
tion). This underlines the fact that while it was not feas-
ible to define objective hypertension as per the ESC
guidelines ‘at least 2 blood pressure measurements per
visit and at least 2 to 3 visits’ [33], our method was vali-
dated and has been used in other international studies
estimating hypertension prevalence.
Another key finding of our study was the discrepancy be-
tween self-reported and objective prevalence of hyperten-
sion (37% and 64%, respectively). One could suggest that
the self-reported and the objective measures are not con-
temporary (i.e. in the past one truly did not have hyperten-
sion but in the interval has developed it) and this induces
discrepancy. However on analysis 90% of the sample had
attended their physician or hospital in the past year.
A study based on data from the Health Survey for
England found that objective hypertension (similarlydefined as ≥140/90 or being on treatment for blood
pressure) was observed in 30% of individuals of which
34% were unaware of the diagnosis [23]. The ‘lack of
awareness’ figure is comparable to our findings however
we find much higher objective prevalence, the corollary
of which is that the impact of such ‘unawareness’ is
much more sinister in terms of public health. Whether
the crux of the problem is that hypertension is not sim-
ply being diagnosed/is suboptimally managed or whether
poor patient awareness is the main factor, is not clear. Is
there a socioeconomic reason for the discrepancy? Given
that previous studies have suggested that hypertension
control rates in Europe are low [23], we attempted to
gain clearer understanding by disentangling the propor-
tions of those on antihypertensive medication in the
context of socioeconomic gradient.
We discovered that of our entire sample 36% were not
hypertensive, 26% were appropriately managed, 19%
were not treated to target and finally 19% were un-
treated. As illustrated in Table 3 and discussed in the re-
sults section, we found that individuals who had
tertiary/higher education and in the highest tertile of the
wealth distribution had a higher probability of being
‘healthy’. Interestingly optimal and suboptimal manage-
ment of hypertension (the latter which could also equate
to non compliance with medication) did not demon-
strate a SEG although those in the middle and highest
tertiles of the wealth distribution did have a lesser
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lyses not detailed here, we tested whether the discrep-
ancy in our results between objective hypertension and
self-report of hypertension was influenced by a SEG in
accuracy of self-report. As per Johnston et al [19] (who
also demonstrated large discrepancy) those at the top of
the education or wealth ladder were less likely to report
false negatively (p < 0.05).
Focusing then on hypercholesterolemia, there was once
again a demonstrated discrepancy between the self-report
and objective measure, prevalence being 41.1% and 72.1%
respectively. In terms of SEG, the wealthier were more
likely to self-report elevated cholesterol however this asso-
ciation was not sustained objectively. Commercially there
is widespread advertisement of low cholesterol spreads
and it is likely this raises public awareness of hypercho-
lesteraemia over hypertension. Interpreting self-report as
patient awareness, this suggests perhaps that these individ-
uals have been influenced by the media and are more
likely to seek and pay for screening than lower socioeco-
nomic classes.
The more educated did demonstrate a higher probabil-
ity of having elevated HDL-C, which represents a more
‘positive’ lipid profile. Banks et al. [11] and Muennig et
al. [34] used data from 1999/2002 NHANES in similar
studies to ours, the former looking at HDL-C and the
latter at both LDL-C and HDL-C. Their results also
demonstrated no SEG in LDL-C. Despite no SEG, we
found that a high proportion of our population have ele-
vated LDL-C, also a primary target of dyslipidemia ther-
apy to reduce cardiovascular risk.
It is difficult to explain the SEG in HDL-C given that
we adjusted for use of cholesterol-lowering medication
in separate analyses and this made no difference. One
could argue that this was because participants were not
fasting. However we have previously demonstrated that
there was no statistically significant difference between
fasting and non-fasting samples in population studies.
Limitations of this study exist in relation to our car-
diovascular measures. Our methodology for diagnosis of
objective hypertension, while used in other extant large
scale population studies including the Health and Retire-
ment Study (HRS) and the English Longitudinal Study
on Ageing (ELSA), is not in adherence with either the
American Heart Association, nor the European Cardi-
ology Society guidelines for diagnosis of hypertension,
according to which diagnosis should be based on blood
pressure measurements taken repeatedly over a period
of time. It must be therefore acknowledged that it is pos-
sible our prevalence levels may be an overestimation,
and include those with ‘white-coat hypertension’ and
also those who are on antihypertensive medications for
reasons other than hypertension. Nevertheless we do not
consider that this nullifies the large discrepancy we haveillustrated in prevalence rates between self-report and
objective hypertension. In terms of objective lipid profile,
the samples were not fasting, which is the gold standard,
however as discussed above we do not consider that this
altered the measure significantly.
Strengths of the study are the large nationally repre-
sentative sample size and the availability both self-
reported and objective cardiovascular measures. This en-
abled more insightful investigation into the epidemiology
of these prevalent health conditions.
Conclusions
In conclusion we surmise that hypertension has a higher
prevalence in Ireland than in other European countries
and that Ireland fares poorly at achieving blood pressure
targets in those on treatment. Lower SES groups are at
more risk of hypertension and should be aggressively
screened and if commenced on medication our results
suggest being less wealthy or less educated will not influ-
ence likelihood of achieving treatment targets. This SEG
in health is more evident using objective measures. There
likely is a combination of poor patient awareness (which
itself demonstrates a SEG) and undiagnosed hypertension
contributing the discrepancy between self-report and ob-
jective measures. In terms of abnormal lipid profile, we in-
terpret that there was no SEG although in analyses not
detailed here we found that those in the highest tertile of
the wealth gradient were more likely to report having high
cholesterol when they truly did (p < 0.10).
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